ISIN | LU1169821458 |
---|---|
Valor Number | 26750016 |
Bloomberg Global ID | UKUSD SW |
Fund Name | UBS (Lux) Fund Solutions – UBS MSCI United Kingdom UCITS ETF hUSD acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
Asset Class | Equities |
EFC Category | Equity United Kingdom |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund aims to track, before expenses, the price and income performance of the price of the MSCI United Kingdom Index (Net Return) (this sub-fund's "Index"). Additionally currency hedged share classes aim to reduce the impact of currency fluctuations between their reference currency and the index currency by selling currency forwards at the one-month forward rate in accordance with the hedging methodology of the Index's currency-hedged index variant. |
Peculiarities |
Current Price * | 25.06 USD | 01.08.2025 |
---|---|---|
Previous Price * | 25.23 USD | 31.07.2025 |
52 Week High * | 25.27 USD | 24.07.2025 |
52 Week Low * | 21.16 USD | 09.04.2025 |
NAV * | 25.06 USD | 01.08.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 3,417,969,076 | |
Unit/Share Assets *** | 550,063,666 | |
Trading Information SIX |
YTD Performance | +12.72% |
31.12.2024 - 01.08.2025
31.12.2024 01.08.2025 |
---|---|---|
YTD Performance (in CHF) | -0.18% |
31.12.2024 - 01.08.2025
31.12.2024 01.08.2025 |
1 month | +3.31% |
01.07.2025 - 01.08.2025
01.07.2025 01.08.2025 |
3 months | +7.06% |
01.05.2025 - 01.08.2025
01.05.2025 01.08.2025 |
6 months | +7.47% |
03.02.2025 - 01.08.2025
03.02.2025 01.08.2025 |
1 year | +12.64% |
01.08.2024 - 01.08.2025
01.08.2024 01.08.2025 |
2 years | +27.23% |
01.08.2023 - 01.08.2025
01.08.2023 01.08.2025 |
3 years | +37.10% |
01.08.2022 - 01.08.2025
01.08.2022 01.08.2025 |
5 years | +86.95% |
03.08.2020 - 01.08.2025
03.08.2020 01.08.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
AstraZeneca PLC | 8.20% | |
---|---|---|
HSBC Holdings PLC | 8.13% | |
Shell PLC | 7.65% | |
Unilever PLC | 5.26% | |
Rolls-Royce Holdings PLC | 4.05% | |
British American Tobacco PLC | 3.70% | |
RELX PLC | 3.42% | |
BP PLC | 3.08% | |
GSK PLC | 2.72% | |
BAE Systems PLC | 2.60% | |
Last data update | 29.07.2025 |
TER | 0.23% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.23% |
Ongoing Charges *** | 0.23% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |